| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunityBio, Inc. | Director | Stock Option (right to buy) | 163K | Jun 18, 2025 | Direct | ||
| NantHealth, Inc. | Director | Stock Option (right to buy) | 100K | Jun 9, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | Jun 18, 2025 | 1 | $0 | 4 | Jun 20, 2025 | Director |
| IBRX | ImmunityBio, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| IBRX | ImmunityBio, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| IBRX | ImmunityBio, Inc. | Jun 5, 2023 | 3 | $198K | 4 | Jun 5, 2023 | Director |
| IBRX | ImmunityBio, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| NHIQ | NantHealth, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| NHIQ | NantHealth, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Director |
| IBRX | ImmunityBio, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |